299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03617718 (ClinicalTrials.gov)	November 1, 2018	19/7/2018	Project 2 Airway Potential Hydrogen (pH) in Asthma	Methods to Identify and Treat Severe Asthma Patients Project 2: Airway pH Phenotyping	Cystic Fibrosis;Asthma;Severe Persistent Asthma;Healthy	Drug: Glycine Buffer	University Hospitals Cleveland Medical Center	National Institutes of Health (NIH);National Heart, Lung, and Blood Institute (NHLBI)	Recruiting	18 Years	50 Years	All	75	Phase 1/Phase 2	United States
2	NCT02558127 (ClinicalTrials.gov)	May 2015	15/6/2015	Asthma With Hypersecretion-associated Gene for Cystic Fibrosis	Asthma With Hypersecretion-associated Gene for Cystic Fibrosis Clinical, Inflammatory and Genetics Characterization	Asthma	Genetic: Asthma patients	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	NULL	Completed	18 Years	80 Years	Both	100	N/A	Spain